ArticleThe Lancet. Infectious diseases2017
The relentless march of cryptococcal meningitis.
Article in The Lancet. Infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Effects of novel organoantimony compounds on the fungal pathogenJournal of medical microbiology · 2025Article
- Cytokine dynamics in the blood and cerebrospinal fluid of HIV/AIDS patients with cryptococcal meningitis receiving antifungal therapy.Frontiers in cellular and infection microbiology · 2025Article
- Lack of Association between Fluconazole Susceptibility andJournal of fungi (Basel, Switzerland) · 2022Article
- The Change in the Neutrophil/Lymphocyte Ratio Predicts the Prognosis of Patients with Cryptococcal Meningitis.Mycopathologia · 2021Article
- Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis.BMC infectious diseases · 2021Article
- A preliminary study on the characteristics of Th1/Th2 immune response in cerebrospinal fluid of AIDS patients with cryptococcal meningitis.BMC infectious diseases · 2021Article
- Review
- Prevalence of cryptococcal antigen (CrAg) among HIV-positive patients in Eswatini, 2014-2015.African journal of laboratory medicine · 2020Article
- Infectious particle identity determines dissemination and disease outcome for the inhaled human fungal pathogen Cryptococcus.PLoS pathogens · 2019Article
- Laboratory-Reflex Cryptococcal Antigen Screening Is Associated With a Survival Benefit in Tanzania.Journal of acquired immune deficiency syndromes (1999) · 2019Article
- Resistance and Tolerance to Cryptococcal Infection: An Intricate Balance That Controls the Development of Disease.Frontiers in immunology · 2019Review
- A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda.Medicine · 2018Observational
- Searching for a change: The need for increased support for public health and research on fungal diseases.PLoS neglected tropical diseases · 2018Article
- Cryptococcal Disease in the Era of "Test and Treat": Is There Cause for Concern?Open forum infectious diseases · 2018Article
- The war on cryptococcosis: A Review of the antifungal arsenal.Memorias do Instituto Oswaldo Cruz · 2018Review
- Host response to pulmonary fungal infections: A highlight on cell-driven immunity toCurrent pharmacology reports · 2017Article
- IPVirulence · 2017Article
- High rates of cerebral toxoplasmosis in HIV patients presenting with meningitis in Accra, Ghana.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2017Article
- Neglected disease, neglected populations: the fight against Cryptococcus and cryptococcosis.Memorias do Instituto Oswaldo CruzArticle
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
28483416What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.